Johnson & Johnson offered $8.9 billion to settle years-old lawsuits claiming that its talcum powder products caused cancer.
The New Jersey-based pharmaceutical giant described their proposal, which still needs a bankruptcy court’s approval, as an equitable and efficient resolution to all claims arising from cosmetic talc litigation.
If approved by the bankruptcy court and a majority of the claimants, the $8.9 billion deal would rank alongside those reached by cigarette corporations and opioid producers as one of the largest product liability settlements ever in the US
Thousands of claims have been filed against J&J because of talcum powder that may have contained traces of asbestos and was linked to ovarian cancer.
The company has never acknowledged wrongdoing, but as of May 2020, it no longer sells its talc-based baby powder in the US and Canada.
The $8.9 billion would be paid to the tens of thousands of claimants over 25 years through a J&J subsidiary, LTL Management LLC, which was set up to address the claims and has filed for bankruptcy protection.
A previous settlement involving LTL was rejected by an appellate court.


Novo Nordisk Raises 2026 Outlook on Strong Wegovy Demand
Elon Musk Says Anthropic Leads AI Race as Claude Models Challenge OpenAI
SK Hynix Soars 13% in Nasdaq Debut After Record $26.5 Billion IPO
DOJ Grand Jury Investigates UAW President Shawn Fain Ahead of Union Election
US Stock Futures Slide as Iran Conflict Escalates Ahead of Key Q2 Earnings Week
Trump, Canada Reach Gordie Howe Bridge Deal Ahead of July 27 Opening
Brazil Court Bars Flavio Bolsonaro From Visiting Jair Bolsonaro Ahead of Election
Kitron Q2 Revenue Beats Estimates as Defense Demand Lifts Growth
Goldman Sees Foreign Investors Driving India Stock Market Recovery
CDC Expands Ebola Screening Efforts at U.S. Entry Points Amid Congo and Uganda Outbreak
White House Seeks $1.4 Billion to Combat Growing Ebola Outbreak
Dollar Holds Steady Ahead of U.S. CPI as Oil Surge, Middle East Tensions Keep Markets on Edge
Dollar Eases as Middle East Conflict, Fed Outlook and Japan Pension Policy Drive FX Markets
Fed Reaffirms 2% Inflation Goal, Vows Forceful Action to Anchor Price Expectations
Supreme Court Asked to Reinstate Mail-Order Access to Abortion Pill Mifepristone
Singapore GDP Grows 5.7% in Q2 2026 as AI-Driven Manufacturing Boosts Economy
China Trade Surplus Hits $125.6 Billion as June Exports, Imports Smash Forecasts 



